Page 34 - ISS e Telemedicina
P. 34

16. Joshi AU, Randolph FT, Chang AM, Slovis BH, Rising KL, Sabonjian M, Sites FD, Hollander JE. Impact
    of Emergency Department Tele-intake on left without being seen and throughput metrics. Acad Emerg
    Med. 2020 Feb;27(2):139-147. doi: 10.1111/acem.13890. Epub 2019 Dec 26.

17. du Toit M, Malau-Aduli B, Vangaveti V, Sabesan S, Ray RA. Use of telehealth in the management of
    non-critical emergencies in rural or remote emergency departments: A systematic review. J Telemed
    Telecare. 2019 Jan;25(1):3-16. doi:10.1177/1357633X17734239. Epub 2017 Oct 5.

18. Gadzinski AJ, Ellimoottil C, Odisho AY, Watts KL, Gore JL. Implementing telemedicine in response to
    the 2020 COVID-19 pandemic. J Urol. 2020 Apr 3:101097JU0000000000001033. doi:
    10.1097/JU.0000000000001033.

19. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020 Mar 11. doi:
    10.1056/NEJMp2003539.

20. Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020 Mar
    25;368:m1182. doi:10.1136/bmj.m1182.

21. Rockwell KL, Gilroy AS. Incorporating telemedicine as part of COVID-19 outbreak response systems.
    Am J Manag Care. 2020 Apr;26(4):147-148. doi: 10.37765/ajmc.2020.42784.

22. Weinstein RS, Krupinski EA, Doarn CR. Clinical examination component of telemedicine, telehealth,
    mhealth, and connected health medical practices. Med Clin North Am. 2018 May;102(3):533-544. doi:
    10.1016/j.mcna.2018.01.002.

23. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei
    Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q,
    Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
    Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

24. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X,
    Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia
    in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-
    6736(20)30211-7. Epub 2020 Jan 30.

25. World Health Organization (WHO). Report of the WHO-China Joint Mission on Coronavirus Disease
    2019 (COVID-19) 2020 (cited 2020 1 March). Available from: https://www.who.int/docs/default-
    source/coronaviruse/who-china-jointmission-on-covid-19-final-report.pdf .

26. National Health Commission & State Administration of Traditional Chinese Medicine. Diagnosis and
    treatment protocol for novel coronavirus pneumonia (Trial Version 7), March 3, 2020.
    https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVI
    D-19.V7.pdf.

27. Chinese Center for Disease Control and Prevention. Epidemic update and risk assessment of 2019
    Novel Coronavirus 2020 (updated 29 January 2020; cited 2020 29 February).
    http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf .

28. Han YN, Feng ZW, Sun LN, Ren XX, Wang H, Xue YM, Wang Y, Fang Y. A comparative-descriptive
    analysis of clinical characteristics in 2019-Coronavirus-infected children and adults. J Med Virol. 2020
    Apr 6. doi: 10.1002/jmv.25835.

29. Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, Ma H, Chen W, Lin Y, Zheng Y, Wang J, Hu Z, Yi Y, Shen
    H. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close
    contacts in Nanjing, China. Sci China Life Sci. 2020 Mar 4. doi:10.1007/s11427-020-1661-4.

30. Mash B. Primary care management of the coronavirus (COVID-19). S Afr Fam Pract (2004). 2020 Mar
    31;62(1):e1-e4. doi: 10.4102/safp.v62i1.5115.

                                                        28
   29   30   31   32   33   34   35   36   37   38